Zydus Lifesciences Limited (ZYDUSLIFE) receives final approval from USFDA for Ascorbic Acid Injection, gaining 180-day CGT exclusivity.
Alembic Pharmaceuticals Limited (APLLTD) receives final approval from USFDA for Tretinoin Cream USP, 0.05%, with an estimated market size of US$ 76 million.
Caplin Point Laboratories Limited (CAPLIPOINT) secures USFDA approval for Foscarnet Sodium Injection, a significant milestone for its subsidiary Caplin Steriles.